MediWound (MDWD) Other Accumulated Expenses (2013 - 2025)
MediWound (MDWD) posted quarterly Other Accumulated Expenses of $4.5 million for Q4 2025, up 27.42% year-over-year from $3.6 million in Q4 2024, and up 22.2% quarter-over-quarter from $3.7 million in Q3 2025.
MediWound (MDWD) Other Accumulated Expenses (2013 - 2025) Analysis & Trends
MediWound's Other Accumulated Expenses history runs 13 years deep, the most recent figure standing at $4.5 million for Q4 2025.
- In Q4 2025, Other Accumulated Expenses rose 27.42% year-over-year to $4.5 million; the TTM figure through Dec 2025 stood at $4.5 million (up 27.42% YoY), while the FY2025 annual figure was $4.5 million, up 27.42% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $4.5 million, up from $3.7 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $5.2 million in Q1 2021, with the low at $2.7 million in Q3 2024.
- The 5-year median for Other Accumulated Expenses is $3.5 million (2024), against an average of $3.6 million.
- The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses plunged 40.93% in 2022, then surged 39.19% in 2025.
- MediWound's Other Accumulated Expenses stood at $3.6 million in 2021, then climbed by 14.89% to $4.2 million in 2022, then decreased by 6.44% to $3.9 million in 2023, then decreased by 8.61% to $3.6 million in 2024, then grew by 27.42% to $4.5 million in 2025.
- Business Quant data shows MDWD's Other Accumulated Expenses at $4.5 million in Q4 2025, $3.7 million in Q3 2025, and $3.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.53 Mn |
| Sep 30, 2025 | 3.71 Mn |
| Jun 30, 2025 | 3.38 Mn |
| Mar 31, 2025 | 3.34 Mn |
| Dec 31, 2024 | 3.56 Mn |
| Sep 30, 2024 | 2.66 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 3.89 Mn |
| Sep 30, 2023 | 3.07 Mn |
| Jun 30, 2023 | 2.82 Mn |
| Mar 31, 2023 | 3.72 Mn |
| Dec 31, 2022 | 4.16 Mn |
| Sep 30, 2022 | 2.99 Mn |
| Jun 30, 2022 | 3.06 Mn |
| Mar 31, 2022 | 3.06 Mn |
| Dec 31, 2021 | 3.62 Mn |
| Sep 30, 2021 | 4.38 Mn |
| Jun 30, 2021 | 3.92 Mn |
| Mar 31, 2021 | 5.17 Mn |